Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents.
Carvalho MFL, de Almeida BO, Bueno MLP, Vicari HP, Lima K, Rego EM, Roversi FM, Machado-Neto JA. Carvalho MFL, et al. Among authors: rego em. Hematol Transfus Cell Ther. 2024 Jul-Sep;46(3):273-282. doi: 10.1016/j.htct.2023.11.007. Epub 2023 Dec 31. Hematol Transfus Cell Ther. 2024. PMID: 38326180 Free PMC article.
Therapeutic plasma exchange and HLA desensitization.
Rego EM. Rego EM. Hematol Transfus Cell Ther. 2024 Jan-Mar;46(1):1-2. doi: 10.1016/j.htct.2024.02.001. Epub 2024 Feb 16. Hematol Transfus Cell Ther. 2024. PMID: 38395736 Free PMC article. No abstract available.
Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia.
Chiesa S, Rego EM, Teich V, Madeira MIA, de Figueiredo Pontes LL, Traina F, Marani LO. Chiesa S, et al. Among authors: rego em. Hematol Transfus Cell Ther. 2024 Apr 17:S2531-1379(24)00075-0. doi: 10.1016/j.htct.2024.02.028. Online ahead of print. Hematol Transfus Cell Ther. 2024. PMID: 38719723 Free article.
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia.
Lima K, Nogueira FL, Cipelli M, Carvalho MFL, Pereira-Martins DA, da Silva WF, Cavaglieri RC, Nardinelli L, Leal AM, Velloso EDRP, Bendit I, Câmara NOS, Schuringa JJ, Machado-Neto JA, Rego EM. Lima K, et al. Among authors: rego em. Eur J Pharmacol. 2024 Aug 15;977:176723. doi: 10.1016/j.ejphar.2024.176723. Epub 2024 Jun 6. Eur J Pharmacol. 2024. PMID: 38851560
197 results